🇺🇸 FDA
Company

IOVANCE

IOVANCE BIOTHERAPEUTICS, INC.

IOVA biotech USA

Quick answer

IOVANCE is a biotech company (IOVA) headquartered in SAN CARLOS, CA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

Lifileucel plus Pembrolizumab

Metastatic Melanoma

Phase 3 · mab · active

1 trials project

Aldesleukin

Bone Sarcoma

Phase 2 · mab · active

1 trials project

Autologous Tumor Infiltrating Lymphocytes MDA-TIL

Malignant Solid Neoplasm

Phase 2 · mab · terminated

1 trials project

Cyclophosphamide

Clinical Stage IV Cutaneous Melanoma AJCC v8

Phase 2 · small_molecule · completed

1 trials project

Cyclophosphamide

Metastatic Bladder Urothelial Carcinoma

Phase 2 · small_molecule · terminated

1 trials project

E7 TCR-T cells

Cervical Cancer

Phase 2 · mab · active

1 trials project

E7 TCR-T cells

HPV-Associated Cervical Carcinoma

Phase 2 · mab · active

1 trials project

IOV-3001

Unresectable Melanoma

Phase 2 · mab · active

1 trials project

IOV-4001

Unresectable Melanoma

Phase 2 · mab · active

1 trials project

LN-145

Squamous Cell Carcinoma of the Head and Neck

Phase 2 · mab · completed

1 trials project

LN-145

Cervical Carcinoma

Phase 2 · mab · terminated

1 trials project

LN-145

Non Small Cell Lung Cancer

Phase 2 · mab · terminated

1 trials project

LN-145

Metastatic Non Small Cell Lung Cancer

Phase 2 · mab · active

1 trials project

LN-145

Cutaneous Squamous Cell Carcinoma

Phase 2 · mab · active

1 trials project

Lifileucel

Melanoma (Skin Cancer)

Phase 2 · mab · active

1 trials project

Lifileucel

Endometrial Cancer

Phase 2 · mab · active

1 trials project

Lifileucel

Metastatic Melanoma

Phase 2 · mab · completed

2 trials project

Tumor infiltrating lymphocytes (TIL) LN-145

Metastatic Triple Negative Breast Cancer

Phase 2 · small_molecule · completed

1 trials project

Cyclophosphamide

Locally Advanced Melanoma

Phase 1 · small_molecule · active

1 trials project

IOV-2001

Chronic Lymphocytic Leukemia

Phase 1 · mab · completed

1 trials project

Interleukin-2

Chronic Graft Versus Host Disease

Phase 1 · small_molecule · active

1 trials project

KK-LC-1 TCR-T cells

Gastric Cancer

Phase 1 · mab · active

1 trials project

LN-144

Stage IIIB Melanoma

Phase 1 · mab · terminated

1 trials project

LN-145/LN-144

Soft Tissue Sarcoma

Phase 1 · mab · active

1 trials

Patents (8)

patent

US 12343380

Expansion of TILs utilizing AKT pathways inhibitors

Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12280140

Processes for production of tumor infiltrating lymphocytes and uses of the same

Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12233075

Remnant tumor infiltrating lymphocytes and methods of preparing and using the sa

Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12230378

Systems and methods for coordinating manufacturing of cells for patient-specific

Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12226434

Processes for production of tumor infiltrating lymphocytes and uses of same in i

Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12230379

Systems and methods for coordinating manufacturing of cells for patient-specific

Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12194061

Processes for production of tumor infiltrating lymphocytes and uses of same in i

Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12188048

Restimulation of cryopreserved tumor infiltrating lymphocytes

Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)